About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 190 record(s)
Req # A-2023-00013
Provide all documents from January 1, 2022 to July 12, 2023 on reducing the carbon impact of space travel and the impact space travel could have on carbon levels.Organization: Canadian Space Agency
November 2023
Req # A-2023-00023
I would like a copy of the following memo: BN0016620 (ISED Briefing Note number)Organization: Canadian Space Agency
November 2023
Req # A-2023-00024
I request any files, data, and correspondence related to any UAP (Unidentified Anomalous Phenomena/Unidentified Aerial Phenomena) Objects, as well as any technology, materials or anything biological retrieved from them. These objects or phenomena may have been detected on the surface of Earth, in the air, underwater, in space, the atmosphere or possibly subterranean. These records may include, but are not limited to: the objects' functions, method of propulsion, as well as affiliation to any human or non-human nation-state, organization, or entity. The exploitation of any of these UAP Objects, technology (including any derived technologies), and materials would also be relevant to this request.Organization: Canadian Space Agency
November 2023
Req # A-2023-00025
The search period is January 1, 2023 to October 6, 2023. All emails, reports, memos and other records that were received/or sent by either the President, Chief of Staff, Senior Advisor (Liaison, Relations and Policy), Vice President (Space Program Policy), Vice President (Science and Technology), Director General (Space Science and Technology), Director General (Space Utilization), Director General (Space Policy) or Counsellor Space Affairs (Washington, DC) that include any reference to either "Sky Canada Project", "UAP", "unidentified aerial phenomena", "unidentified anomalous phenomena" or "UFO".Organization: Canadian Space Agency
November 2023
Req # A-2023-00026
Please provide records showing the total cost of office furniture purchased by your department during the fiscal years of 2019-2020, 2020-2021, 2021-2022 and 2022-2023. Provide annual totals for those years as well. Also provide the breakdown of individual purchases, as well as a description of the item or items purchased and the corresponding costs.Organization: Canadian Space Agency
November 2023
Req # A-2021-000075
All records pertaining to the initial identification of something other than Creutzfeldt-Jakob Disease (CJD) in possible CJD referral cases in New Brunswick, that something was amiss or something inexplicable was happening. Date range: January 1, 2015 - May 11, 2021.Organization: Public Health Agency of Canada
November 2023
Req # A-2021-000365
Documents related to work on the isolation, description, classification and recording of the SARS-Cov-2 virus and its comparison to viruses and pathogens previously studied and referenced by the laboratory. Documents related to the laboratory's development of the reagent for detecting COVID-19 by public health laboratories in Canada. Documents related to the reagent's ability to detect the SARS-Cov-2 virus. Documents related to the laboratory's development of tests for detecting the SARS-Cov-2 virus and/or COVID-19. Documents related the review, analysis, benchmarking, comparison and validation of the various tests for detecting and screening COVID019 authorized by Health Canada, marketed and used across the country to detect COVID-19 and the SARS-Cov-2 virus. Documents related to the review, analysis and ability of diagnostic tests approved by Health Canada to detect the SARS-Cov-2 virus. Documents related to the laboratory's work in examining the correlation between the results of polymerase chain reaction (PCR) tests conducted, the estimation of viral load, the number of amplification cycles needed to detect the virus and the effective and isolated presence of the SARS-Cov-2 virus verified by culturing samples collected from individuals who had a positive result from a diagnostic test approved by Health Canada. Documents related to the laboratory's review, analysis and monitoring of the effectiveness of vaccines used in Canada to prevent and combat COVID-19 and the SARS-Cov-2 virus. Documents, data books and analyses related to the frequency of co-infections in samples collected from people with COVID-19 identified by laboratory culturing. Documents that identify, date and analyze culturing, samples from people declared positive for COVID-19, conducted since the start of 2020 by the laboratory and its annexes and provincial partners.Organization: Public Health Agency of Canada
November 2023
Req # A-2021-000488
All briefing notes or memos pertaining to COVID-19 testing requirements for travellers prepared for the Vice-President level or higher. November 1, 2021 to November 17, 2021.Organization: Public Health Agency of Canada
November 2023
Req # A-2021-000623
All documents related to the decision to implement an exemption from quarantine hotels for Canadians returning from compassionate travel abroad effective approximately May 27, 2021.Organization: Public Health Agency of Canada
November 2023
Req # A-2022-000134
The three documents listed below, included as references in the document "An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI); Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age" Published July 14, 2022: Skowronski D. Personal communication. SARS-CoV-2 sero prevalence and vaccine effectiveness (VE) update: focus on children 5-11 years, British Columbia. 2022 May 30. COVID-19 Immunity Task Force (CITF). Personal communication. Vaccine strategies in an era of hybrid immunity. 2022 June 3. Moderna. Personal Communication. 2022 Jun 21.Organization: Public Health Agency of Canada
November 2023